![American Gastroenterological Association American Gastroenterological Association](https://54d4f314-8f94-415c-acb7-fd0a6332f070.s3.amazonaws.com/374/374__aga-logo-lg__-1706585740.png?X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAU2BE4PNFKE2WZV7V%2F20240908%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240908T001138Z&X-Amz-SignedHeaders=host&X-Amz-Expires=86400&X-Amz-Signature=8c07651d019798a8151bc91d56dc8fccb89e569fcd6c26cd0e2a44c43a0f7e19)
Asymptomatic Neoplastic Pancreatic Cysts
Publication Date: April 1, 2015
Key Points
Key Points
Pancreatic cysts are common and increase with age, but the development of invasive adenocarcinoma in these cysts is extremely rare.
The incidental identification of pancreatic cysts is common with the growing use of sophisticated abdominal imaging techniques.
Approximately 15% of patients undergoing abdominal magnetic resonance imaging (MRI) for other indications harbor unsuspected pancreatic cysts.
The management strategy for pancreatic cysts aims to prevent the development of invasive cancer and/or to resect invasive malignancy early when present.
Current clinical practice is based on minimal evidence and relies almost exclusively on case series of frequent cross-sectional imaging with or without endoscopic ultrasonography (EUS) and/or fine-needle aspiration (FNA) cytology and surgery for concerning features.
The AGA recommends that before starting any pancreatic cyst surveillance program, patients should have a clear understanding of programmatic risks and benefits.
The incidental identification of pancreatic cysts is common with the growing use of sophisticated abdominal imaging techniques.
Approximately 15% of patients undergoing abdominal magnetic resonance imaging (MRI) for other indications harbor unsuspected pancreatic cysts.
The management strategy for pancreatic cysts aims to prevent the development of invasive cancer and/or to resect invasive malignancy early when present.
Current clinical practice is based on minimal evidence and relies almost exclusively on case series of frequent cross-sectional imaging with or without endoscopic ultrasonography (EUS) and/or fine-needle aspiration (FNA) cytology and surgery for concerning features.
The AGA recommends that before starting any pancreatic cyst surveillance program, patients should have a clear understanding of programmatic risks and benefits.
Diagnosis
Diagnosi...
...AGA suggests that patients with pancrea...
...ts that pancreatic cysts with at least 2 high-ri...
...AGA suggests that patients without conc...
...e AGA suggests that significant ch...
Management
...agement...
...gests against continued surveillance of pancrea...
...ts that patients with both a solid component...
...AGA recommends that if surgery is con...
...AGA suggests that patients with inva...
...AGA suggests against routine surveillance of pan...
Management of Asymptomatic Neoplastic Pancreatic Cysts
...of Asymptomatic Neoplastic Pancre...